Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide** is a synthetic small molecule belonging to the phenylpyrrolidine class of organic compounds. It has the molecular formula C10H11N3O5S and a molecular weight of approximately 285.28 g/mol[1][8]. The compound is primarily studied as an experimental inhibitor of carbonic anhydrase enzymes, particularly carbonic anhydrase II, with high potency (IC50 ~0.62 nM)[4][8]. Carbonic anhydrases are zinc-containing enzymes involved in the reversible hydration of carbon dioxide and play roles in pH regulation and ion transport. Inhibition of these enzymes can be relevant for conditions such as glaucoma, epilepsy, edema, and some cancers; however, this compound has not been approved for any clinical use or indication[4]. Its main application remains in biochemical research as a tool compound for studying enzyme inhibition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3-nitro-4-(2-oxo-pyrrolidin-1-yl)-benzenesulfonamide.